Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (24)

1

Deep sequencing analysis of HIV‐1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE

enthalten in: Journal of medical virology | 2016

von Van Eygen, V. | Thys, K. | Van Hove, C. | +5

2

Trends in Darunavir Resistance-Associated Mutations and Phenotypic Resistance in Commercially Tested United States Clinical Samples between 2006 and 2012

enthalten in: Aids research and human retroviruses | 2015

von Lathouwers, E. | Gupta, S. | Haddad, M. | +3

3

Trends in Darunavir Resistance-Associated Mutations and Phenotypic Resistance in Commercially Tested United States Clinical Samples Between 2006 and 2012

enthalten in: Aids research and human retroviruses | 2015

von Lathouwers, E. | Gupta, S. | Haddad, M. | +3

4

Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir

enthalten in: Journal of clinical virology | 2015

von Fevery, B. | Susser, S. | Lenz, O. | +7

5

Assessment of etravirine resistance in HIV-1-infected paediatric patients using population and deep sequencing: final results of the PIANO study

enthalten in: Antiviral therapy | 2015

von Tambuyzer, L. | Thys, K. | Hoogstoel, A. | +5

6

An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay

enthalten in: Journal of clinical microbiology | 2015

von Sarrazin, C. | Dierynck, I. | Cloherty, G. | +7

7

Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region

enthalten in: Antiviral research | 2015

von Sarrazin, C. | Lathouwers, E. | Peeters, M. | +11

8

Low‐density lipoprotein and other predictors of response with telaprevir‐based therapy in treatment‐experienced HCV genotype 1 patients: REALIZE study

enthalten in: Liver international | 2015

von Berg, T. | Andreone, P. | Pol, S. | +13

9

Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies

enthalten in: Journal of hepatology | 2015

von De Meyer, S. | Verbinnen, T. | Fevery, B. | +8

10

Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection

enthalten in: Journal of clinical virology | 2014

von Picchio, G. | De Meyer, S. | Dierynck, I. | +10